Skip to main content
. 2021 Jul 27;11:15261. doi: 10.1038/s41598-021-94754-9

Table 1.

Patient demographics and characteristics.

AIH (N = 52) ASC (N = 14) p value
Patient demographics
Female (%) 23 (60.5%) 5 (45.5%) 0.37
Age (years) 14.4 ± 3.4 14.2 ± 3.0 0.83
BMI (kg/m2) 20.4 ± 4.1 21.4 ± 3.8 0.46
Time from diagnosis to MRI (years) 2.2 ± 2.1 2.9 ± 3.7 0.71
Liver biochemistry
Total Bilirubin (mg/dL) 1.1 ± 1.7 0.8 ± 0.4 0.47
ALT (IU/L) 181.4 ± 347.9 103.8 ± 103.9 0.39
AST (IU/L) 168.4 ± 355.7 104.4 ± 132.9 0.26
GGT (IU/L) 73.3 ± 128.9 224.8 ± 399.9 0.024
IgG (g/L) 14.0 ± 5.2 14.6 ± 4.9 0.61
Albumin (g/L) 43.1 ± 5.0 42.9 ± 3.0 0.47
Gamma globulins (%) 18.9 ± 6.4 16.6 ± 4.5 0.28
Histology scores
Fibrosis
 Score 0 6 2
 Score 1 10 0
 Score 2 8 2
 Score 3 11 4
 Score 4 7 1
 Score 5 8 3
 Score 6 2 2
Portal inflammation
 Score 0 6 1
 Score 1 17 6
 Score 2 19 6
 Score 3 10 1
Lobular inflammation
 Score 0 17 5
 Score 1 28 5
 Score 2 3 3
 Score 3 4 1

The different section headings, significant p values, and patient groups in the column headers have bold font. They have been put in bold text to aid in the interpretation of the data presented.